PremiumThe FlyPactiv Evergreen downgraded to Neutral from Buy at UBS Pactiv Evergreen downgraded to Neutral from Buy at UBS Pactiv Evergreen downgraded to Sector Perform from Outperform at RBC Capital PremiumCompany AnnouncementsPactiv Evergreen Merges with Novolex in $6.7B Deal Novolex to acquire Pactiv Evergreen for $18.00 per share in cash Apollo’s Novolex exploring bid for Pactiv Evergreen, Bloomberg reports PremiumCompany AnnouncementsPactiv Evergreen’s Q3 2024 Financial Performance and Outlook Pactiv Evergreen Faces Revenue Decline Amid Strategic Shifts Pactiv Evergreen narrows FY24 adjusted EBITDA view to $800M-$820M 
